Senna 7.5mg tablets 12 Years Plus

Nazione: Regno Unito

Lingua: inglese

Fonte: MHRA (Medicines & Healthcare Products Regulatory Agency)

Compra

Foglio illustrativo Foglio illustrativo (PIL)
20-04-2020
Scheda tecnica Scheda tecnica (SPC)
02-03-2020

Principio attivo:

Senna fruit

Commercializzato da:

A A H Pharmaceuticals Ltd

Codice ATC:

A06AB06

INN (Nome Internazionale):

Senna fruit

Dosaggio:

7.5mg

Forma farmaceutica:

Oral tablet

Via di somministrazione:

Oral

Classe:

No Controlled Drug Status

Tipo di ricetta:

Valid as a prescribable product

Dettagli prodotto:

BNF: 01060200; GTIN: 5037563004096

Scheda tecnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Boots Senna Adult Laxative 7.5 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Alexandrian Senna fruit (_Cassia senna _ L. (_C.
acutifolia _
Delile)
fruit)
corresponding
to
7.5
mg
hydroxyanthracene
glycosides,
calculated as sennoside B
3
PHARMACEUTICAL FORM
Tablet
A plain greenish-brown round tablet
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For short term relief of occasional constipation.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral use only.
Adults and the elderly: 1 to 2 tablets to be taken at bedtime.
Should not be used in children or adolescents under the age of 18
years.
The maximum daily dose of hydroxyanthracene glycosides is 15 mg. This
is
equivalent to 2 tablets. The correct individual dose is the smallest
required to
produce a comfortable soft-formed motion.
The dose should be decreased as the bowel habit becomes regular.
Duration of use
Not to be used for more than 1 week. Usually it is sufficient to take
this
medicinal product up to two to three times during that week.
If there is no bowel movement after three days a doctor should be
consulted.
If the symptoms persist during the use of the medicinal product, a
doctor or a
pharmacist should be consulted.
See also section 4.4 Special warnings and precautions for use.
4.3
CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
Cases of intestinal obstructions and stenosis, atony, appendicitis,
inflammatory
colon diseases (e.g. Crohn’s disease, ulcerative colitis) abdominal
pain of
unknown origin, severe dehydration state with water and electrolyte
depletion.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Do not exceed the stated dose.
Should not be used in children or adolescents under the age of 18
years.
Long-term use of stimulant laxatives should be avoided, as use for
more than a
brief period of treatment may lead to impaired function of the
intestine and
dependence on laxatives. If laxatives are needed every day the cause
of the
consti
                                
                                Leggi il documento completo
                                
                            

Cerca alert relativi a questo prodotto